WebBRIM Biotechnology, Inc. engages in the research and development of treatment drugs. It offers medicines for dry eye syndrome, corneal damage repair, neurotrophic keratitis, … WebApr 12, 2024 · Taipei, Taiwan, 6th April 2024, BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative peptide therapies, submitted IND today for BRM424, which received ODD status from the FDA last November. If no comment from the FDA is received within 30 days, BRIM will initiate the …
BRIM Biotechnology strengthens leadership team in preparation …
WebApr 10, 2024 · Brim Biotechnology announces it has entered into a new strategic partnership with Ora Inc. for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). Brim intends to initiate phase 3 clinical studies with Ora’s support later this year. Web2 days ago · Taipei, Taiwan, 6th April 2024, BRIM Biotechnology, Inc.(“BRIM,” TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative peptide therapies, submitted IND today for BRM424, which received ODD status from the FDA last November.If no comment from the FDA is received within 30 days, BRIM will initiate the … jean\\u0027s 5w
BRIM Biotechnology strengthens leadership team
WebMay 16, 2024 · BRIM Biotechnology, Inc. is a clinical-stage company developing novel regenerative therapies in ophthalmology and degenerative joint diseases. Established in July 2013 to accelerate the development and transformation of early research technology platforms to clinical drug candidates, BRIM applies world-leading expertise in … WebDec 2, 2024 · BRIM Biotechnology, Inc. was established in July 2013 to accelerate the development and transformation of early research technology platforms to clinical drug … WebBRIM Biotechnology Inc. submitted an IND today for BRM424, which received ODD status from the FDA last November. If no comment from the FDA is received within 30 days, BRIM will initiate the BRM424 phase 2 study in the first half of 2024. jean\u0027s 5u